Market Overview:
The global oscillating positive expiratory pressure (OPEP) devices market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory disorders. In addition, growing awareness about the benefits of using OPEP devices is also contributing to the market growth. Based on type, the global OPEP devices market is segmented into facemask OPEP devices, mouthpiece OPEP devices, and bottle OPEP devices. The facemask OPEP device segment accounted for a major share of the global market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to factors such as rising demand for portable and easy-to-use medical equipment and increasing adoption of facemask OPPEdevices by healthcare professionals for treatment purposes. Based on application, the global opep Devices Market is segmented into chronic obstructive pulmonary disease (COPD), asthma,, atelectasis,, bronchitis,, bronchiectasis,, cystic fibrosis,.and others).
 Devices Industry Outlook.svg)
Product Definition:
An Oscillating Positive Expiratory Pressure (OPEP) Device is a medical device that delivers positive airway pressure to the lungs during exhalation in order to keep the airways open and improve breathing. OPEP Devices are often used in patients with chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), or cystic fibrosis. The use of an OPEP Device can help prevent respiratory infections, improve lung function, and reduce hospital admissions.
Facemask OPEP Devices:
The global facemask OPEP devices, it's usage and growth factor in the Oscillating Positive Expiratory Pressure (OPEP) Devices market size was valued at USD 4.0 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Mouthpiece OPEP Devices:
Mouthpiece OPP devices are used in oscillating positive expiratory pressure (OPEP) devices. The OPP device is a mouthpiece that helps in creating a vacuum between the teeth and the airway to prevent food from entering into the lungs. It works by creating an artificial lung-like atmosphere around the mouth and teeth, thereby helping patients to breathe easily during sleep or restorative processes.
Application Insights:
Chronic Obstructive Pulmonary Disease (COPD) segment held the largest market share in 2017. COPD is a major public health concern as it leads to death in 10-20% of the patients with the disease. According to estimates reported by Global Burden of Disease Study, COPD was prevalent in approximately 65 million people across the globe and is expected to become one of the most common diseases by 2030. The high prevalence coupled with increasing life expectancy globally has created a huge demand for oscillating positive expiratory pressure devices that are used for treating COPD.
The others application segment includes emphysema, asthma, bronchitis and other related lung infections such as pneumonia and tuberculosis infection among others.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing awareness about COPD are some of the major factors responsible for its growth. In addition, growing preference for home healthcare is also expected to drive demand during the forecast period. Europe accounted for a significant share in terms of revenue due to an increase in R&D investments by various organizations and companies as well as high prevalence of chronic respiratory diseases such as asthma and bronchitis among children & adults.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to large population base suffering from various respiratory disorders such as asthma and other airway related problems that require continuous positive airway pressure (CPAP) therapy or OPP device therapy respectively.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for OPEP devices in the coming years.
- Growing awareness about benefits of OPEP therapy: There is a growing awareness among healthcare professionals and patients about the benefits of using OPEP devices for treating respiratory diseases. This is likely to boost the demand for these devices in the near future.
- Technological advancements in OPEP devices: The technological advancements in OPEP devices are helping to improve their efficacy and safety profile, which is resulting in an increase in their adoption rates worldwide.
- Rising number of geriatric population: The number of geriatric population is rising globally, which is leading to an increase in cases of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma among them. This will create a high demand for OPEP therapy over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oscillating Positive Expiratory Pressure (OPEP) Devices Market Research Report
By Type
Facemask OPEP Devices, Mouthpiece OPEP Devices, Bottle OPEP Devices
By Application
Chronic Obstructive Pulmonary Disease (COPD), Asthma, Atelectasis, Bronchitis, Bronchiectasis, Cystic Fibrosis, Others
By Companies
Smiths Medical, Monaghan Medical Corporation, R. Cegla GmbH & Co. KG, PARI GmbH, AirPhysio, Medica Holdings, LLC, DR Burton Healthcare, SoloPep
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market Report Segments:
The global Oscillating Positive Expiratory Pressure (OPEP) Devices market is segmented on the basis of:
Types
Facemask OPEP Devices, Mouthpiece OPEP Devices, Bottle OPEP Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chronic Obstructive Pulmonary Disease (COPD), Asthma, Atelectasis, Bronchitis, Bronchiectasis, Cystic Fibrosis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Smiths Medical
- Monaghan Medical Corporation
- R. Cegla GmbH & Co. KG
- PARI GmbH
- AirPhysio
- Medica Holdings, LLC
- DR Burton Healthcare
- SoloPep
 Devices Market Overview.svg)
Highlights of The Oscillating Positive Expiratory Pressure (OPEP) Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Facemask OPEP Devices
- Mouthpiece OPEP Devices
- Bottle OPEP Devices
- By Application:
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Atelectasis
- Bronchitis
- Bronchiectasis
- Cystic Fibrosis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oscillating Positive Expiratory Pressure (OPEP) Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Devices Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OPEP devices are a type of CPAP device that use oscillating positive expiratory pressure to help people with sleep apnea breathe more easily. Oscillating positive expiratory pressure helps keep the airway open during sleep, which allows the person to breathe more easily and avoid episodes of apnea.
Some of the key players operating in the oscillating positive expiratory pressure (opep) devices market are Smiths Medical, Monaghan Medical Corporation, R. Cegla GmbH & Co. KG, PARI GmbH, AirPhysio, Medica Holdings, LLC, DR Burton Healthcare, SoloPep.
The oscillating positive expiratory pressure (opep) devices market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oscillating Positive Expiratory Pressure (OPEP) Devices Market - Supply Chain
4.5. Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast
4.5.1. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Absolute $ Opportunity
5. Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Type
5.3.1. Facemask OPEP Devices
5.3.2. Mouthpiece OPEP Devices
5.3.3. Bottle OPEP Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Application
6.3.1. Chronic Obstructive Pulmonary Disease (COPD)
6.3.2. Asthma
6.3.3. Atelectasis
6.3.4. Bronchitis
6.3.5. Bronchiectasis
6.3.6. Cystic Fibrosis
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oscillating Positive Expiratory Pressure (OPEP) Devices Demand Share Forecast, 2019-2026
9. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Application
9.4.1. Chronic Obstructive Pulmonary Disease (COPD)
9.4.2. Asthma
9.4.3. Atelectasis
9.4.4. Bronchitis
9.4.5. Bronchiectasis
9.4.6. Cystic Fibrosis
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Type
9.7.1. Facemask OPEP Devices
9.7.2. Mouthpiece OPEP Devices
9.7.3. Bottle OPEP Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Demand Share Forecast, 2019-2026
10. Latin America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Application
10.4.1. Chronic Obstructive Pulmonary Disease (COPD)
10.4.2. Asthma
10.4.3. Atelectasis
10.4.4. Bronchitis
10.4.5. Bronchiectasis
10.4.6. Cystic Fibrosis
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Type
10.7.1. Facemask OPEP Devices
10.7.2. Mouthpiece OPEP Devices
10.7.3. Bottle OPEP Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oscillating Positive Expiratory Pressure (OPEP) Devices Demand Share Forecast, 2019-2026
11. Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Application
11.4.1. Chronic Obstructive Pulmonary Disease (COPD)
11.4.2. Asthma
11.4.3. Atelectasis
11.4.4. Bronchitis
11.4.5. Bronchiectasis
11.4.6. Cystic Fibrosis
1.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Type
11.7.1. Facemask OPEP Devices
11.7.2. Mouthpiece OPEP Devices
11.7.3. Bottle OPEP Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Demand Share, 2019-2026
12. Asia Pacific Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Application
12.4.1. Chronic Obstructive Pulmonary Disease (COPD)
12.4.2. Asthma
12.4.3. Atelectasis
12.4.4. Bronchitis
12.4.5. Bronchiectasis
12.4.6. Cystic Fibrosis
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Type
12.7.1. Facemask OPEP Devices
12.7.2. Mouthpiece OPEP Devices
12.7.3. Bottle OPEP Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oscillating Positive Expiratory Pressure (OPEP) Devices Demand Share, 2019-2026
13. Middle East & Africa Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Application
13.4.1. Chronic Obstructive Pulmonary Disease (COPD)
13.4.2. Asthma
13.4.3. Atelectasis
13.4.4. Bronchitis
13.4.5. Bronchiectasis
13.4.6. Cystic Fibrosis
13.4.7. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oscillating Positive Expiratory Pressure (OPEP) Devices Market Size and Volume Forecast by Type
13.7.1. Facemask OPEP Devices
13.7.2. Mouthpiece OPEP Devices
13.7.3. Bottle OPEP Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oscillating Positive Expiratory Pressure (OPEP) Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Market Share Analysis
14.2. Oscillating Positive Expiratory Pressure (OPEP) Devices Distributors and Customers
14.3. Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Smiths Medical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Monaghan Medical Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. R. Cegla GmbH & Co. KG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. PARI GmbH
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AirPhysio
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Medica Holdings, LLC
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. DR Burton Healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. SoloPep
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
&nbs
